PPA
RVMD icon

Parametric Portfolio Associates’s Revolution Medicines RVMD Stock Holding History

Parametric Portfolio Associates’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-22,994
Closed -$579K – 3754
2021
Q4 		$579K Sell
22,994
-408
-2% -$11.5K ﹤0.01% 3006
2021
Q3 		$644K Buy
23,402
+7,919
+51% +$230K ﹤0.01% 2990
2021
Q2 		$491K Sell
15,483
-2,723
-15% -$95K ﹤0.01% 3091
2021
Q1 		$835K Buy
18,206
+5,435
+43% +$244K ﹤0.01% 3250
2020
Q4 		$506K Buy
12,771
+4,593
+56% +$182K ﹤0.01% 3380
2020
Q3 		$285K Sell
8,178
-9,094
-53% -$252K ﹤0.01% 3506
2020
Q2 		$545K Buy
+17,272
New +$543K ﹤0.01% 3228

Other funds holding RVMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CG
Column Group San Francisco, California $88.1M AUM 148.03% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Parametric Portfolio Associates's RVMD Position: Q1 2022 in Review

Parametric Portfolio Associates sold out of Revolution Medicines (RVMD) in Q1 2022, closing a stake of 22,994 shares — an estimated $579K sold.

Parametric Portfolio Associates first reported a position in RVMD in Q2 2020 and held it in 7 quarters. The position peaked at $835K in Q1 2021. 126 funds tracked by Wall St. Rank hold RVMD as of Q1 2022.

  • Parametric Portfolio Associates reported no remaining Revolution Medicines position as of Q1 2022 after selling out during the quarter.
  • Parametric Portfolio Associates sold 22,994 Revolution Medicines shares in Q1 2022, an estimated $579K.
  • Parametric Portfolio Associates first reported a position in Revolution Medicines in Q2 2020 and held it in 7 quarters.
  • Parametric Portfolio Associates's Revolution Medicines position peaked at $835K in Q1 2021.
  • 126 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.